Full Text
PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

Abstract

Authors

S. Ostalé P. Ruiz

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×